A Modified Variant of Fasciola hepatica FhSAP-2 (mFhSAP-2) as a Recombinant Vaccine Candidate Induces High-Avidity IgG2c Antibodies and Enhances T Cell Activation in C57BL/6 Mice
Riseilly Ramos-Nieves(University of Puerto Rico, Medical Sciences Campus), Ana M. Espino(University of Puerto Rico, Medical Sciences Campus)
Cited by 1
Related Papers
The mechanisms underlying the immune control of Zika virus infection at the maternal-fetal interface
|Frontiers in Immunology|2022|7